News

University of Queensland researchers are recruiting healthy volunteers with a family history of early-onset cardiovascular disease for an innovative trial aimed at preventing cardiac disease.

Medical devices developed from research at The University of Queensland have been the subject of a major sales agreement with China.

A new drug with the potential to reverse or slow the development of asthma is being tested by researchers at The University of Queensland.

University of Queensland scientists are honing in on drug-resistant tuberculosis (TB) in a project which could lead to new antibiotics.

Scientists at The University of Queensland have teamed up with the peak body for Australian athletes, the Australian Athletes’ Alliance, to tackle concussion and its long-term effects.

University of Queensland pain drug pioneer Professor Maree Smith has joined an elite group of scientists tonight, receiving the prestigious ATSE Clunies Ross Award.

Superbug research from Monash University and The University of Queensland could change the way critically ill patients across the world are treated.

University of Queensland immunologist Dr Kirsty Short has been identified in a nationwide hunt for leading early-career researchers with a flair for communicating their work.

The tropical archerfish can recognise people and spit at familiar faces, researchers from The University of Queensland and University of Oxford have found.

A prototype cancer vaccine which could be used against a variety of diseases including leukaemia, melanoma and prostate cancer is being developed in Queensland.

University of Queensland researchers have discovered a key driver in the development of most cancers, including breast, lung, liver and ovarian cancers.

Experts are calling for a national register of cost-effective drugs for public hospitals as medical advances push up the cost of the Pharmaceutical Benefits Scheme (PBS).

UQ School of Public Health's Master of Public Health (MPH) program is the first in Australia to achieve Curriculum Validation from the Agency for Public Health Education Accreditation (APHEA), one of the leading accrediting bodies for MPH programs in the world.

Parents of children with attention deficit hyperactivity disorder (ADHD) are hoping a University of Queensland trial could help their families get a decent night’s sleep.

The Centre of Research Excellence for the Study of Naevi was officially launched in April.

About one-third of the global disease burden for mental, neurological and substance use disorders occurs in India and China, according to University of Queensland research released today.

After 43 years of continuous service, including more than 20 years as a Professor, Jake Najman is retiring from The University of Queensland.

A prestigious scholarship is helping University of Queensland alumnus Dr Nick Gattas pursue dreams of a prototype private hospital harnessing technology to treat chronic illness.

Research from The University of Queensland has found that the public health burden of mental, neurological, and substance use (MNS) disorders, as estimated by disability-adjusted life years, increased by 41 per cent between 1990 and 2010 and now accounts for one in every 10 lost years of health globally.